Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Clinical Relevance of- Limit of Detection (LOD) - Limit of Quantification (LOQ) - Based Flow Cytometry Approach for Measurable Residual Disease (MRD) Assessment in Acute Myeloid Leukemia (AML)

Raffaele Palmieri, MD, Alfonso Piciocchi, Valentina Arena, MS, Luca Maurillo, Maria Ilaria Del Principe, Giovangiacinto Paterno, Tiziana Ottone, Mariadomenica Divona, Serena Lavorgna, Maria Irno Consalvo, Consuelo Conti, Cristina Attrotto, Daniela Fraboni, Maria Teresa Voso, MD, William Arcese, MD PhD, Adriano Venditti, MD, Francesco Buccisano, MD

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-139557

Published: 2020

Journal Articles

Multiparametric Flow-Cytometry Is a Reliable Tool for Measurable Residual Disease Assessment and Risk-Stratification of FLT3-Mutated AML Patients

Blood (2019) 134 (Supplement_1): 5083.

https://doi.org/10.1182/blood-2019-129184

Published: 2019

Journal Articles

Leukemic Stem Cells Persistence Measured By Multiparametric Flow Cytometry Is a Biomarker of Poor Prognosis in Adult Patients with Acute Myeloid Leukemia

Francesco Buccisano, MD, Raffaele Palmieri, MD, Maria Irno Consalvo, Alfonso Piciocchi, Luca Maurillo, Maria Ilaria Del Principe, Valentina Arena, Stefano Soddu, Ambra Di Veroli, MD, Giovangiacinto Paterno, Eleonora De Bellis, Daniela Fraboni, Consuelo Conti, Maria Teresa Voso, MD, William Arcese, Adriano Venditti

Blood (2019) 134 (Supplement_1): 2688.

https://doi.org/10.1182/blood-2019-128025

Published: 2019

Journal Articles

Pattern of Central Nervous System (CNS) Involvement in Adult Acute Myeloid Leukemia (AML) and Its Impact on Outcome

Blood (2016) 128 (22): 2789.

https://doi.org/10.1182/blood.V128.22.2789.2789

Published: 2016

Journal Articles

Age-Stratified Analysis Of The Prognostic Role Of Minimal Residual Disease Detection By Flow Cytometry, In Adult Patients With Acute Myeloid Leukemia

Francesco Buccisano, MD, Luca Maurillo, MD, Alfonso Piciocchi, PhD, Maria Ilaria Del Principe, MD, Chiara Sarlo, MD, Mariagiovanna Cefalo, MD, Concetta Ditto, MD, Ambra Di Veroli, MD, Daniela Nasso, MD, Marco Refrigeri, MD, Maria Antonietta Irno Consalvo, PhD, Daniela Fraboni, PhD, Consuelo Conti, Giovanni Del Poeta, MD, Francesco Lo Coco, MD, Sergio Amadori, Adriano Venditti, MD

Blood (2013) 122 (21): 2649.

https://doi.org/10.1182/blood.V122.21.2649.2649

Published: 2013

Journal Articles

Decreased Apoptosis in Bone Marrow of Pediatric Patients After HLA-Identical Stem Cell Transplantation for African Sickle Cell Anemia

Antonella Isgrò, Marco Marziali, Pietro Sodani, Javid Gaziev, MD, Daniela Fraboni, Katia Paciaroni, Maria Domenica Simone, Gioia De Angelis, Cecilia Alfieri, Cristiano Gallucci, Andrea Roveda, Fabio Torelli, Luisa Cardarelli, Michela Ribersani, Guido Lucarelli

Blood (2012) 120 (21): 4751.

https://doi.org/10.1182/blood.V120.21.4751.4751

Published: 2012

Journal Articles

Rapid Increase of CD8+ T Cell Count in Peripheral Blood of Pediatric Patients After HLA-Identical Stem Cell Transplantation for African Sickle Cell Anemia

Antonella Isgrò, Marco Marziali, Pietro Sodani, Javid Gaziev, Daniela Fraboni, Katia Paciaroni, Maria Domenica Simone, Gioia De Angelis, Cecilia Alfieri, Cristiano Gallucci, Andrea Roveda, Fabio Torelli, Luisa Cardarelli, Michela Ribersani, Guido Lucarelli

Blood (2012) 120 (21): 4769.

https://doi.org/10.1182/blood.V120.21.4769.4769

Published: 2012

Journal Articles

MRD-Directed Post-Remissional Therapy Dramatically Improves Outcome of Adult Patients with High Risk AML by Implementing Allogeneic Transplant Option

Blood (2010) 116 (21): 2702.

https://doi.org/10.1182/blood.V116.21.2702.2702

Published: 2010

Journal Articles

Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia

Blood (2010) 116 (13): 2295–2303.

https://doi.org/10.1182/blood-2009-12-258178

Published: 2010

Includes: Supplemental data

Journal Articles

Immunological Evaluation after Haematopoietic Stem Cell Transplantation for B–Thalassemia Major

Marco Marziali, Antonella Isgro, Javid Gaziev, Daniela Fraboni, PhD, Paola Polchi, Sr., Pietro Sodani, Cecilia Alfieri, Katia Paciaroni, Cristiano Gallucci, Guido Lucarelli

Blood (2008) 112 (11): 4371.

https://doi.org/10.1182/blood.V112.11.4371.4371

Published: 2008

Journal Articles

Donor’s NK Cells May Influence the Engraftment in Pediatrics Patients after T-Cell Depleted Haploidentical Stem Cell Transplant for Thalassemia

Antonella Isgro, MD, PhD, Marco Marziali, Pietro Sodani, Javid Gaziev, MD, Paola Polchi, Sr., Gioia De Angelis, Daniela Fraboni, PhD, Wilma Leti, MD, Fernando Aiuti, Guido Lucarelli

Blood (2008) 112 (11): 4595.

https://doi.org/10.1182/blood.V112.11.4595.4595

Published: 2008

Journal Articles

Detection of Minimal Residual Disease by Flow-Cytometry Otimizes Risk Stratification When Combined with Cytogenetics in AML.

Francesco Buccisano, MD, Luca Maurillo, MD, Giovanni Del Poeta, MD, Maria Ilaria Del Principe, MD, Paola Panetta, PhD, Daniela Fraboni, PhD, Maria Irno Consalvo, PhD, Daniela Renzi, MD, Selenia Campagna, MD, Chiara Sarlo, MD, Luca Franceschini, MD, Laura Giannì, MD, Emanuele Ammatuna, MD, Francesco Lo Coco, MD, Sergio Amadori, MD, Adriano Venditti, MD

Blood (2007) 110 (11): 4242.

https://doi.org/10.1182/blood.V110.11.4242.4242

Published: 2007

Journal Articles

Flow-Cytometric Minimal Residual Disease Determination Is a Surrogate Prognosticator in Adult AML Patients Lacking Specific Molecular Signatures.

Francesco Buccisano, MD, Luca Maurillo, MD, Giovanni Del Poeta, MD, Maria Ilaria Del Principe, MD, Daniela Fraboni, PhD, Emanuele Ammatuna, MD, Maria Irno Consalvo, PhD, Paola Panetta, PhD, Licia Ottaviani, MD, Sabrina Faccia, MD, Manuela Rizzo, MD, Massimiliano Postorino, MD, Maria Cantonetti, MD, Francesco Lo Coco, MD, Sergio Amadori, MD, Adriano Venditti, MD

Blood (2007) 110 (11): 3498.

https://doi.org/10.1182/blood.V110.11.3498.3498

Published: 2007

Journal Articles

Statistical Validation of a Threshold To Discriminate Flow-Cytometry Minimal Residual Disease (MRD) Levels with Prognostic Significance in Acute Myeloid Leukemia (AML).

Francesco Buccisano, MD, Luca Maurillo, MD, Valter Gattei, MD, Giovanni Del Poeta, MD, Maria Ilaria Del Principe, MD, Paola Panetta, Phd, Daniela Fraboni, Phd, Maria Irno Consalvo, Phd, Licia Ottaviani, MD, Daniela Renzi, MD, Sabrina Faccia, MD, Chiara Sarlo, MD, Francesco Lo Coco, MD, Sergio Amadori, MD, Adriano Venditti, MD

Blood (2006) 108 (11): 2299.

https://doi.org/10.1182/blood.V108.11.2299.2299

Published: 2006

NARROW

Clinical Relevance of- Limit of Detection (LOD) - Limit of Quantification (LOQ) - Based Flow Cytometry Approach for Measurable Residual Disease (MRD) Assessment in Acute Myeloid Leukemia (AML)

Multiparametric Flow-Cytometry Is a Reliable Tool for Measurable Residual Disease Assessment and Risk-Stratification of FLT3-Mutated AML Patients

Leukemic Stem Cells Persistence Measured By Multiparametric Flow Cytometry Is a Biomarker of Poor Prognosis in Adult Patients with Acute Myeloid Leukemia

Pattern of Central Nervous System (CNS) Involvement in Adult Acute Myeloid Leukemia (AML) and Its Impact on Outcome

Age-Stratified Analysis Of The Prognostic Role Of Minimal Residual Disease Detection By Flow Cytometry, In Adult Patients With Acute Myeloid Leukemia

Decreased Apoptosis in Bone Marrow of Pediatric Patients After HLA-Identical Stem Cell Transplantation for African Sickle Cell Anemia

Rapid Increase of CD8+ T Cell Count in Peripheral Blood of Pediatric Patients After HLA-Identical Stem Cell Transplantation for African Sickle Cell Anemia

MRD-Directed Post-Remissional Therapy Dramatically Improves Outcome of Adult Patients with High Risk AML by Implementing Allogeneic Transplant Option

Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia

Immunological Evaluation after Haematopoietic Stem Cell Transplantation for B–Thalassemia Major

Donor’s NK Cells May Influence the Engraftment in Pediatrics Patients after T-Cell Depleted Haploidentical Stem Cell Transplant for Thalassemia

Detection of Minimal Residual Disease by Flow-Cytometry Otimizes Risk Stratification When Combined with Cytogenetics in AML.

Flow-Cytometric Minimal Residual Disease Determination Is a Surrogate Prognosticator in Adult AML Patients Lacking Specific Molecular Signatures.

Statistical Validation of a Threshold To Discriminate Flow-Cytometry Minimal Residual Disease (MRD) Levels with Prognostic Significance in Acute Myeloid Leukemia (AML).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only